A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans [10]

Diabetes Care

Volumn 26, Issue 8, 2003, Pages 2477-2478

  Yamakawa, Jun'ichi ^b   Takahashi, Takashi ^b   Itoh, Tohoru ^b   Kusaka, Kazuya ^b   Kawaura, Ken ^b   Wang, Xin Qui ^b   Kanda, Tsugiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; PLASMA PROTEIN; SARPOGRELATE; SEROTONIN; SEROTONIN 2A ANTAGONIST; TRIACYLGLYCEROL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIINFLAMMATORY ACTIVITY; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CRYESTHESIA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; LETTER; MALE; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RISK FACTOR; SENSORY DYSFUNCTION; SKIN ULCER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADIPONECTIN; AGED; ARTERIOSCLEROSIS OBLITERANS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTEINS; SEROTONIN ANTAGONISTS; SUCCINATES;

EID: 0042524519     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.8.2477     Document Type: Letter

References (7)

1. Tsunekawa T, Hayashi T, Suzuki Y, Matsui-Hirai H, Kano H, Fukatsu A, Nomura N, Miyazaki A, Iguchi A: Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care 26:285-289, 2003
2. Piol C, Fontbonne A, Sultan A, Rasamisoa M, Mariano-Goulant D, Davy JM, Monnier L, Avignon A: Inflammatory parameters are independent predictors of severe epicardial coronary stenosis in asymptomatic diabetic patients with silent myocardial ischemia. Diabetes Care 26:545-546, 2003
3. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599, 2000
4. Katz MF, Farber HW, Dodds-Stitt Z, Cruikshank WW, Beer DJ: Serotonin-stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factor. J Leukoc Biol 55:567-573, 1994
5. Maxwell C: Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol 6:15-24, 1978
6. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kadowaki T: A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45:740-743, 2002
7. Takahashi T, Yano M, Minami J, Haraguchi T, Koga N, Higashi K, Kobori S: Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy. Diabetes Res Clin Pract 58:123-129, 2002